246 related articles for article (PubMed ID: 26690041)
1. Structural insights into BMP receptors: Specificity, activation and inhibition.
Yadin D; Knaus P; Mueller TD
Cytokine Growth Factor Rev; 2016 Feb; 27():13-34. PubMed ID: 26690041
[TBL] [Abstract][Full Text] [Related]
2. The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway.
Katagiri T; Tsukamoto S
Biol Chem; 2013 Jun; 394(6):703-14. PubMed ID: 23324379
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
4. Specification of BMP Signaling.
Nickel J; Mueller TD
Cells; 2019 Dec; 8(12):. PubMed ID: 31817503
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein receptor signal transduction in human disease.
Gomez-Puerto MC; Iyengar PV; García de Vinuesa A; Ten Dijke P; Sanchez-Duffhues G
J Pathol; 2019 Jan; 247(1):9-20. PubMed ID: 30246251
[TBL] [Abstract][Full Text] [Related]
6. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.
Groppe J; Hinck CS; Samavarchi-Tehrani P; Zubieta C; Schuermann JP; Taylor AB; Schwarz PM; Wrana JL; Hinck AP
Mol Cell; 2008 Feb; 29(2):157-68. PubMed ID: 18243111
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
[TBL] [Abstract][Full Text] [Related]
8. Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva.
Lanchoney TF; Olmsted EA; Shore EM; Gannon FA; Rosen V; Zasloff MA; Kaplan FS
Clin Orthop Relat Res; 1998 Jan; (346):38-45. PubMed ID: 9577408
[TBL] [Abstract][Full Text] [Related]
9. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
[TBL] [Abstract][Full Text] [Related]
10. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva.
Hino K; Ikeya M; Horigome K; Matsumoto Y; Ebise H; Nishio M; Sekiguchi K; Shibata M; Nagata S; Matsuda S; Toguchida J
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15438-43. PubMed ID: 26621707
[TBL] [Abstract][Full Text] [Related]
11. [BMP signaling and bone formation].
Katagiri T
Clin Calcium; 2012 Nov; 22(11):1677-83. PubMed ID: 23103811
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H.
Ohte S; Shin M; Sasanuma H; Yoneyama K; Akita M; Ikebuchi K; Jimi E; Maruki Y; Matsuoka M; Namba A; Tomoda H; Okazaki Y; Ohtake A; Oda H; Owan I; Yoda T; Furuya H; Kamizono J; Kitoh H; Nakashima Y; Susami T; Haga N; Komori T; Katagiri T
Biochem Biophys Res Commun; 2011 Apr; 407(1):213-8. PubMed ID: 21377447
[TBL] [Abstract][Full Text] [Related]
13. BMP signaling in vascular diseases.
Cai J; Pardali E; Sánchez-Duffhues G; ten Dijke P
FEBS Lett; 2012 Jul; 586(14):1993-2002. PubMed ID: 22710160
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein receptors: Structure, function and targeting by selective small molecule kinase inhibitors.
Sanchez-Duffhues G; Williams E; Goumans MJ; Heldin CH; Ten Dijke P
Bone; 2020 Sep; 138():115472. PubMed ID: 32522605
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of BMP-Receptor Interaction and Activation.
Mueller TD
Vitam Horm; 2015; 99():1-61. PubMed ID: 26279372
[TBL] [Abstract][Full Text] [Related]
16. Receptor oligomerization and beyond: a case study in bone morphogenetic proteins.
Heinecke K; Seher A; Schmitz W; Mueller TD; Sebald W; Nickel J
BMC Biol; 2009 Sep; 7():59. PubMed ID: 19735544
[TBL] [Abstract][Full Text] [Related]
17. Structural perspective of BMP ligands and signaling.
Gipson GR; Goebel EJ; Hart KN; Kappes EC; Kattamuri C; McCoy JC; Thompson TB
Bone; 2020 Nov; 140():115549. PubMed ID: 32730927
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
Glister C; Kemp CF; Knight PG
Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
[TBL] [Abstract][Full Text] [Related]
19. Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA.
de la Peña LS; Billings PC; Fiori JL; Ahn J; Kaplan FS; Shore EM
J Bone Miner Res; 2005 Jul; 20(7):1168-76. PubMed ID: 15940369
[TBL] [Abstract][Full Text] [Related]
20. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.
Nickel J; Dreyer MK; Kirsch T; Sebald W
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S7-14. PubMed ID: 11263668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
